Priorità di accesso alla vaccinazione anti-SARS-CoV-2/COVID-19: questione di valori, non solo di fatti

Translated title of the contribution: [Autom. eng. transl.] Priority for access to anti-SARS-CoV-2 / COVID-19 vaccination: a question of values, not just facts

Research output: Contribution to journalArticle

Abstract

[Autom. eng. transl.] One of the thorniest issues accompanying the debate on the anti-SARS-CoV-2 / COVID- vaccination campaign 19 is the one concerning access to vaccines, that is the order of priority to be followed, especially in the initial phase of administration, characterized by a strong imbalance between supply and demand. In Italy, access is regulated by the Italy's strategic plan for the anti-SARS-CoV-2 / COVID-19 vaccination of December 2020, which was followed by an update document of February 2021. The objective of this contribution is to analyze from one point of view the two documents are ethical, examining in particular the theme of the justifications that are the basis of the choices made and their classification with respect to the egalitarian perspective of the Italian National Health Service (NHS)
Translated title of the contribution[Autom. eng. transl.] Priority for access to anti-SARS-CoV-2 / COVID-19 vaccination: a question of values, not just facts
Original languageItalian
Pages (from-to)25-34
Number of pages10
JournalMEDICINA E MORALE
Publication statusPublished - 2021

Keywords

  • SARS-CoV-2
  • vaccino
  • COVID-19

Fingerprint

Dive into the research topics of '[Autom. eng. transl.] Priority for access to anti-SARS-CoV-2 / COVID-19 vaccination: a question of values, not just facts'. Together they form a unique fingerprint.

Cite this